FFA
CGON icon

Farther Finance Advisors’s CG Oncology CGON Stock Holding History

Farther Finance Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.69K Buy
38
+9
+31% +$661 ﹤0.01% 5296
2026
Q2 		$2.06K Buy
29
+5
+21% +$327 ﹤0.01% 5161
2026
Q1 		$1.6K Buy
24
+14
+140% +$793 ﹤0.01% 4968
2025
Q4 		$415 Hold
10
– – ﹤0.01% 5087
2025
Q3 		$403 Buy
+10
New +$291 ﹤0.01% 4588

Other funds holding CGON

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

Farther Finance Advisors's CGON Position: Q3 2026 in Review

Farther Finance Advisors increased its CG Oncology (CGON) stake by 31% in Q3 2026, buying an estimated $661 and bringing the position to 38 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #5296.

Farther Finance Advisors first reported a position in CGON in Q3 2025 and has held it in 5 quarters since. 8 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • Farther Finance Advisors held 38 shares of CG Oncology worth $2.69K as of Q3 2026.
  • Farther Finance Advisors bought 9 CG Oncology shares in Q3 2026, an estimated $661.
  • CG Oncology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5296 holding.
  • Farther Finance Advisors first reported a position in CG Oncology in Q3 2025 and has held it in 5 quarters since.
  • 8 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.